KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Goodwill (2020 - 2023)

Historic Goodwill for Bionano Genomics (BNGO) over the last 4 years, with Q2 2023 value amounting to $77.3 million.

  • Bionano Genomics' Goodwill rose 3737.87% to $77.3 million in Q2 2023 from the same period last year, while for Jun 2023 it was $77.3 million, marking a year-over-year increase of 3737.87%. This contributed to the annual value of $77.3 million for FY2022, which is 3762.29% up from last year.
  • As of Q2 2023, Bionano Genomics' Goodwill stood at $77.3 million, which was up 3737.87% from $77.3 million recorded in Q1 2023.
  • Bionano Genomics' Goodwill's 5-year high stood at $77.3 million during Q4 2022, with a 5-year trough of $6.9 million in Q3 2020.
  • For the 4-year period, Bionano Genomics' Goodwill averaged around $41.1 million, with its median value being $56.2 million (2021).
  • In the last 5 years, Bionano Genomics' Goodwill skyrocketed by 334.25% in 2021 and then skyrocketed by 68720.2% in 2022.
  • Over the past 4 years, Bionano Genomics' Goodwill (Quarter) stood at $7.2 million in 2020, then soared by 682.94% to $56.2 million in 2021, then surged by 37.62% to $77.3 million in 2022, then fell by 0.01% to $77.3 million in 2023.
  • Its Goodwill was $77.3 million in Q2 2023, compared to $77.3 million in Q1 2023 and $77.3 million in Q4 2022.